From GlobeNewswire: 2025-02-17 09:00:00

The global Oxytocic Pharmaceuticals Market was valued at USD 121.51 million in 2023, expected to reach USD 239.81 million by 2032, growing at a CAGR of 7.86%. Demand for maternal health treatments, especially for postpartum hemorrhage, is driving market expansion. Major players include App Pharmaceuticals LLC, Teva Parenteral Medicines Inc., and Abbott Laboratories.

Postpartum hemorrhage (PPH) segment led the market in 2023, accounting for 48.7% share. PPH remains a major health concern globally, leading to high maternal morbidity and mortality. Synthetic oxytocin held 69.5% market share in 2023, known for its safety and efficacy in managing labor and PPH. Hospitals were the largest end-user segment, accounting for 78.3% market share in 2023.

In 2023, North America dominated the market with a 49.8% share, attributed to advanced healthcare infrastructure and high spending on healthcare. The Asia-Pacific region is witnessing the fastest growth due to increased investments in healthcare and programs focusing on maternal health in countries like India and China. The demand for oxytocic pharmaceuticals in the region is on the rise due to the increasing number of childbirths and focus on maternal care. Insud Pharma secured USD 2.7 million funding from the Bill & Melinda Gates Foundation for a Phase II clinical trial on a novel sublingual oxytocin treatment to prevent postpartum hemorrhage.

The Oxytocic Pharmaceuticals Market Analysis & Outlook Report 2024-2032 offers insights on market dynamics, statistics, trends, and competitive landscape. It covers incidence of labor induction & postpartum hemorrhage, prescription trends, regulatory updates, healthcare spending, and more. Access the complete report for in-depth analysis and company profiles.

SNS Insider, a leading market research and consulting agency, provides valuable insights for clients to navigate changing market conditions. Through surveys, video talks, and focus groups globally, they deliver current and accurate market data, consumer insights, and opinions to help clients make informed decisions with confidence.



Read more at GlobeNewswire: Oxytocic Pharmaceuticals Market Size to Hit USD 239.81